The share price of Adcock Ingram Holdings Ltd. (JSE: AIP), South Africa's largest pharmaceutical company, rose on Friday to a two-year high, after the company said that it had received offers to buy the company or a controlling stake, states South Africa's "Business Report". The newspaper added that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) was one of the companies was had expressed an interest in buying the company
"Business Report" also mentioned Sanofi SA (Euronext: SAN; NYSE: SNY), Baxter International Inc. (NYSE: BAX), and Reckitt-Benckiser plc (LSE: RB).
Adcock Ingram's products include Panado painkillers and Corenza cold medicine. The company's share price rose 8.9% to 67.50 rand on the Johannesburg Stock Exchange on Friday, its highest level since November 2010, giving a market cap of $1.3 billion.
Adcock Ingram has a marketing and distribution agreement with Merck & Co. (NYSE: MRK) for the sale of non-prescription and hypertension drugs. JPMorgan says that a bidding war for Adcock Ingram could push its share price up to 75.80 rand.
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments